Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer
暂无分享,去创建一个
Caleb F. Davis | Marshall W. Anderson | Claire L. Simpson | D. Wheeler | M. Spitz | C. Amos | M. You | S. Tsavachidis | Ping Yang | M. de Andrade | J. Bailey-Wilson | A. Schwartz | F. Kheradmand | C. Simpson | D. Mandal | S. Pinney | G. Armstrong | Yanhong Liu | M. Scheurer | E. Kupert | Donghai Xiong | C. Pikielny | C. Gaba
[1] R. Elston,et al. Increased familial risk for lung cancer. , 1986, Journal of the National Cancer Institute.
[2] Terri K. Attwood,et al. PRINTS and its automatic supplement, prePRINTS , 2003, Nucleic Acids Res..
[3] D. Corry,et al. An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.
[4] D. Gudbjartsson,et al. Familial risk of lung carcinoma in the Icelandic population. , 2004, JAMA.
[5] Marshall W. Anderson,et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.
[6] M. Hutz,et al. Polymorphisms in the DBH and DRD2 gene regions and smoking behavior , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[7] Robert D. Finn,et al. Pfam: clans, web tools and services , 2005, Nucleic Acids Res..
[8] Mike Tyers,et al. BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..
[9] R. D'Agostino,et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.
[10] H. Coxson,et al. Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.
[11] G. O'Connor,et al. Framingham Heart Study genome-wide association: results for pulmonary function measures , 2007, BMC Medical Genetics.
[12] Marshall W. Anderson,et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. , 2008, Journal of the National Cancer Institute.
[13] Y. Shugart,et al. A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). , 2008, Preventive medicine.
[14] M. Spitz,et al. Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans , 2008, Cancer Prevention Research.
[15] H. Coxson,et al. Lung Myeloid Dendritic Cells Coordinately Induce TH1 and TH17 Responses in Human Emphysema , 2009, Science Translational Medicine.
[16] M. Sternberg,et al. Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.
[17] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[18] E. Diamandis,et al. Nidogen-2: a new serum biomarker for ovarian cancer. , 2010, Clinical biochemistry.
[19] V. Salomaa,et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia , 2010, Nature Genetics.
[20] Jonathan C. Cohen,et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.
[21] A. Hofman,et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function , 2010, Nature Genetics.
[22] Ming D. Li,et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.
[23] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[24] D. Conti,et al. Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies , 2011, Genetic epidemiology.
[25] C. Lamina. Digging into the extremes: a useful approach for the analysis of rare variants with continuous traits? , 2011, BMC proceedings.
[26] Aleksandar Milosavljevic,et al. An integrative variant analysis suite for whole exome next-generation sequencing data , 2012, BMC Bioinformatics.
[27] R. Irizarry,et al. NID2 and HOXA9 Promoter Hypermethylation as Biomarkers for Prevention and Early Detection in Oral Cavity Squamous Cell Carcinoma Tissues and Saliva , 2011, Cancer Prevention Research.
[28] J. Hokanson,et al. Genome-wide association study of smoking behaviours in patients with COPD , 2012 .
[29] Joshua M. Korn,et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.
[30] P. Prorok,et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. , 2011, Journal of the National Cancer Institute.
[31] M. Rieder,et al. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis , 2012, Nature Genetics.
[32] H. Hakonarson,et al. Two-Stage Extreme Phenotype Sequencing Design for Discovering and Testing Common and Rare Genetic Variants: Efficiency and Power , 2012, Human Heredity.
[33] Q. Wang,et al. Clinical significance of decreased nidogen‐2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma , 2012, Journal of surgical oncology.
[34] T. Kosten,et al. Association of functional dopamine-beta-hydroxylase (DBH) 19bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers , 2012, Schizophrenia Research.
[35] B. Qian,et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia , 2012, Nature Genetics.
[36] A. López-Guillermo,et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia , 2013, Nature Genetics.
[37] J. Lupski,et al. Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy , 2013, Genome Medicine.
[38] Simon White,et al. Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline , 2014, BMC Bioinformatics.
[39] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[40] Thomas M. Keane,et al. POT1 loss-of-function variants predispose to familial melanoma , 2014, Nature Genetics.
[41] R. Gibbs,et al. Germline mutations in shelterin complex genes are associated with familial glioma. , 2015, Journal of the National Cancer Institute.